Navigation Links
TGen's Huentelman and Weiss named to 2013 Class of 40 Under 40

PHOENIX, Ariz. June 5, 2013 Dr. Matt Huentelman of the Translational Genomics Research Institute (TGen) and Dr. Glen Weiss of TGen and Cancer Treatment Centers of America (CTCA) are among the 40 business leaders under 40 years of age named by the Phoenix Business Journal to its 13th Annual Class of 40 Under 40.

They will be honored at an awards ceremony June 27 at the Phoenix Art Museum.

Dr. Huentelman, Ph.D., is an Associate Professor in TGen's Neurogenomics Division, where he oversees research programs focused on sensory disorders, including hearing and vision loss, and on aging and age-related diseases, such as Alzheimer's disease and the genetics of learning and memory highlighted recently by the launch of TGen's MindCrowd project (

Dr. Huentelman also is the Co-Director of TGen's Center for Rare Childhood Disorders, which investigates uncommon neurologic problems among children, often those that are only a collection of symptoms with no diagnosis.

"I am honored to be selected among the 40 Under 40 by the Phoenix Business Journal," Dr. Huentelman said. "This recognition serves to highlight the significant advances that TGen has made through the study of the human genome, and the insights and breakthroughs being made, not only by me, but by our entire scientific staff every day."

Dr. Weiss, M.D., is a Clinical Associate Professor in TGen's Cancer and Cell Biology Division and is Director of Clinical Research at CTCA. His research focuses on genomic and other 'omics characterizations of lung cancer, rare cancers and early-detection strategies.

Dr. Weiss has been selected by CTCA at Western Regional Medical Center to head the startup of a new clinical research program in Goodyear, Ariz. Dr. Weiss is also Co-Unit Head of TGen's Lung Cancer Research Laboratory.

"As a research scientist, being a member of the 40 Under 40 is a reflection of the collaborations I am privileged to conduct through TGen and CTCA," Dr. Weiss said. "As a medical doctor, these collaborations lead to new therapies that can help the patients that look to us for healing and hope."

The 40 Under 40 program's hundreds of alumni includes Phoenix Mayor Greg Stanton, a member of the TGen Board of Directors, and Arizona Diamondbacks President Derrick Hall, a member of TGen's National Advisory Council for Pancreatic Cancer Research.


Contact: Steve Yozwiak
The Translational Genomics Research Institute

Related biology news :

1. LSUHSCs Weiss chosen to help set national eye policy, research
2. Carnegies Greg Asner named Energy/Climate Fellow by US State Department
3. John A. Kaufman named 2012 Dotter Lecturer by Society of Interventional Radiology Foundation
4. Researchers aim to assemble the tree of life for all 2 million named species
5. UMass Medical School scientist named 2012 Pew Latin-American Fellow in the Biomedical Sciences
6. Top young Latin-American scientists named Pew Biomedical Fellows
7. Kendall L. Carder named recipient of the Jerlov Award
8. Winners named in 2012 AAAS Kavli Science Journalism Award Competition
9. Michael Barnett of Boston College named Professor of the Year for Massachusetts
10. Cultural anthropologist Mark Flinn named 2013 AAAS Fellow
11. Kansas State University scientists named American Association for the Advancement of Science fellows
Post Your Comments:
(Date:11/17/2015)... Paris , qui ... Paris , qui s,est tenu du ... leader de l,innovation biométrique, a inventé le premier scanner ... sur la même surface de balayage. Jusqu,ici, deux scanners ... les empreintes digitales. Désormais, un seul scanner est en ...
(Date:11/12/2015)... 2015  A golden retriever that stayed healthy despite ... has provided a new lead for treating this muscle-wasting ... Institute of MIT and Harvard and the University of ... Cell, pinpoints a protective gene that ... effects. The Boston Children,s lab of Lou Kunkel ...
(Date:11/10/2015)... Nov. 10, 2015  In this report, ... basis of product, type, application, disease indication, ... this report are consumables, services, software. The ... safety biomarkers, efficacy biomarkers, and validation biomarkers. ... are diagnostics development, drug discovery and development, ...
Breaking Biology News(10 mins):
(Date:11/26/2015)... , England , November 26, 2015 /PRNewswire/ ... Medical, an innovative medical device company specializing in imaging technologies, ... from the European Commission as part of the Horizon 2020 ... company to carry out a large-scale clinical trial in breast ...      (Logo: , --> ...
(Date:11/25/2015)... HOLLISTON, Mass. , Nov. 25, 2015 /PRNewswire/ ... ), a biotechnology company developing bioengineered organ implants for ... will present at the LD Micro "Main Event" ... p.m. PT. The presentation will be webcast live and ... will also be available at the conference for one-on-one ...
(Date:11/25/2015)... PORTLAND, Oregon , November 25, 2015 /PRNewswire/ ... Deep Market Research Report is a professional and ... Genomics industry.      (Logo: ... basic overview of the industry including definitions, classifications, ... analysis is provided for the international markets including ...
(Date:11/24/2015)... Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will be presenting at ... on Wednesday, December 2 at 9:30 a.m. ET/6:30 a.m. PT ... provide a corporate overview. th Annual Oppenheimer Healthcare ... ET/10:00 a.m. PT . Jim Mazzola , vice president ... --> th Annual Oppenheimer Healthcare Conference in ...
Breaking Biology Technology: